BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 107631)

  • 1. Effect of rabbit anti-human thymocyte globulin on lymphocyte subpopulations and functions following allotransplantation in the rhesus monkey.
    Thomas JM; Carver M; Scott J; Williams E; Thomas F
    Transplantation; 1979 Mar; 27(3):163-70. PubMed ID: 107631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-specific activity in rabbit anti-human thymocyte globulin. Correlation with immunosuppresive activity in nonhuman primates.
    Thomas JM; Williams EA; Thomas FT; Millington GM
    Transplantation; 1978 Mar; 25(3):97-102. PubMed ID: 417439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs.
    Thomas JM; Carver M; Cunningham P; Sash C; Park K; Thomas F
    Transplantation; 1989 Feb; 47(2):209-15. PubMed ID: 2645699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prostaglandin-dependent immunoregulatory mechanism activated by in vivo administration of antithymocyte globulin.
    Thomas JM; Carver FM; Fahrenbruch GB; Hall WR; Deepe RM; Thomas FT
    Surgery; 1983 Aug; 94(2):384-91. PubMed ID: 6224306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome.
    Bieber CP; Griepp RB; Oyer PE; Wong J; Stinson EB
    Transplantation; 1976 Nov; 22(5):478-88. PubMed ID: 793103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression.
    Thomas J; Alqaisi M; Cunningham P; Carver M; Rebellato L; Gross U; Patselas T; Araneda D; Thomas F
    Transplantation; 1992 Feb; 53(2):247-58. PubMed ID: 1531393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac allograft survival in rhesus primates treated with combined total lymphoid irradiation and rabbit antithymocyte globulin.
    Bieber CP; Jamieson S; Raney A; Burton N; Bogarty S; Hoppe R; Kaplan HS; Strober S; Stinson EB
    Transplantation; 1979 Oct; 28(4):347-50. PubMed ID: 116401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.
    Ruggenenti P; Codreanu I; Cravedi P; Perna A; Gotti E; Remuzzi G
    Clin J Am Soc Nephrol; 2006 May; 1(3):546-54. PubMed ID: 17699258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic cytolytic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy.
    Laske A; Gallino A; Schneider J; Bauer EP; Carrel T; Pasic M; von Segesser LK; Turina MI
    J Heart Lung Transplant; 1992; 11(3 Pt 1):557-63. PubMed ID: 1610864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC
    Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Doares W; Kaczmorski S; Farney AC
    Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
    Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
    J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis outbreak in rhesus monkeys immunosuppressed with antithymocyte globulin.
    Fox JG; Murphy JC; Esser RE; Delmonico FL; Cosimi AB
    J Med Primatol; 1975; 7(5):264-73. PubMed ID: 830036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Burnett CM; Thomas FT
    Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
    [No Abstract]   [Full Text] [Related]  

  • 19. Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.
    Cihan Y; Kanzelmeyer N; Drube J; Kreuzer M; Lerch C; Hennies I; Froede K; Verboom M; Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2017 Nov; 32(11):2133-2142. PubMed ID: 28717935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
    Azimzadeh AM; Zhang T; Wu G; Kelishadi SS; Stoddard T; OʼNeill N; Nguyen BN; Welty E; Avon C; Higuchi M; Mitchell SL; Hershfeld A; Cheng XF; Kronfli A; Rybak E; Burdorf L; Pierson RN
    Transplantation; 2017 Jan; 101(1):63-73. PubMed ID: 27362307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.